KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Rigel Pharmaceuticals (RIGL) Long-Term Debt Issuances (2022 - 2023)

Rigel Pharmaceuticals (RIGL) has 2 years of Long-Term Debt Issuances data on record, last reported at $20.0 million in Q1 2023.

  • For Q1 2023, Long-Term Debt Issuances rose 100.0% year-over-year to $20.0 million; the TTM value through Dec 2023 reached $20.0 million, up 2.09%, while the annual FY2023 figure was $20.0 million, 2.09% up from the prior year.
  • Long-Term Debt Issuances reached $20.0 million in Q1 2023 per RIGL's latest filing, up from $9.6 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $20.0 million in Q1 2023 and bottomed at -$33000.0 in Q2 2022.